Clenergy(SH:603628)2023-10-30 16:00Financial Performance - The company's revenue for Q3 2023 was approximately ¥421.70 million, representing a year-over-year increase of 2.06%[4] - The net profit attributable to shareholders for Q3 2023 was approximately ¥37.27 million, a decrease of 6.50% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥35.66 million, down 8.89% year-over-year[4] - The basic earnings per share for Q3 2023 was ¥0.1362, reflecting a decrease of 6.50% compared to the same period last year[6] - Operating profit for the third quarter was ¥175,570,832.99, up from ¥84,481,975.17 in the previous year, representing a growth of 107%[18] - Net profit for the first three quarters of 2023 was ¥144,808,235.68, compared to ¥68,489,171.79 in the same period last year, marking a 111% increase[18] - Basic earnings per share for the third quarter were ¥0.5294, compared to ¥0.2495 in the same quarter of the previous year, representing a growth of 112%[19] Assets and Liabilities - The total assets at the end of Q3 2023 were approximately ¥2.37 billion, an increase of 4.86% from the end of the previous year[6] - Total current assets as of September 30, 2023, amount to ¥1,345,746,239.18, an increase from ¥1,303,712,445.65 in the previous year[15] - Total assets as of September 30, 2023, are ¥2,371,874,327.64, up from ¥2,261,959,676.48 in the previous year[15] - The company reported a total of 4,108,500.00 in receivables financing, down from 16,426,400.44 year-over-year[14] - The company has a total of 30,050,911.33 in long-term equity investments, up from 25,176,344.51 in the previous year[15] - The company's total liabilities decreased to ¥1,143,701,700.62 from ¥1,155,335,457.36 year-over-year, a reduction of approximately 1%[16] - The total equity attributable to shareholders increased to ¥1,221,696,117.18, up from ¥1,099,399,117.61, reflecting an increase of about 11%[16] Cash Flow - The company's operating cash flow for the year-to-date period increased by 131.63% to approximately ¥21.61 million[4] - Cash flow from operating activities for the first three quarters was ¥1,253,563,670.51, an increase from ¥916,407,327.73 in the same period of 2022, reflecting a growth of 37%[21] - The net cash flow from operating activities for Q3 2023 was CNY 21,612,188.88, a significant improvement from a net outflow of CNY 68,331,456.34 in Q3 2022[22] - Total cash inflow from operating activities reached CNY 1,382,839,946.43, compared to CNY 1,040,026,275.08 in the same period last year, reflecting a year-over-year increase of approximately 32.9%[22] - Cash outflow from operating activities was CNY 1,361,227,757.55, up from CNY 1,108,357,731.42 in Q3 2022, indicating a rise of about 22.8%[22] Research and Development - Research and development expenses increased by 73.87% year-over-year, indicating a strong commitment to innovation[9] - Research and development expenses for the first three quarters were ¥29,467,373.40, significantly higher than ¥16,947,496.48 in the previous year, indicating a 74% increase[17] - The company has ongoing development in new products and technologies, although specific details were not disclosed in the provided content[12] Shareholder Information - Total number of common shareholders at the end of the reporting period is 21,179[11] - The largest shareholder, HONG DANIEL, holds 29.73% of shares, totaling 81,407,607 shares[11] Government Support - The company received government subsidies amounting to approximately ¥543,790 in Q3 2023, contributing to its non-recurring gains[8] Other Financial Metrics - The weighted average return on equity decreased by 0.74 percentage points to 3.10% for Q3 2023[6] - The company reported a decrease in other comprehensive income, with a net amount of -¥839,463.71 compared to ¥17,636,231.38 in the previous year[19] - The total liabilities and equity increased to ¥2,371,874,327.64 from ¥2,261,959,676.48, showing an increase of approximately 5%[17] - The ending cash and cash equivalents balance was CNY 184,881,993.03, down from CNY 221,118,367.65 at the end of Q3 2022[23]